Investor Resources
Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Registration statements relating to these securities have been filed with the
This offering was made only by means of a prospectus. Copies of the final prospectus relating to this offering can be obtained from
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About
Contacts:
Chief Financial Officer
IR@crinetics.com
(858) 450-6464
Westwicke Partners
robert.uhl@westwicke.com
(858) 356-5932
Source: Crinetics Pharmaceuticals, Inc.